Jazz Pharmaceuticals plc buy Cantor Fitzgerald
Start price
22.03.24
/
50%
€113.00
Target price
22.03.25
€166.54
Performance (%)
-9.03%
Price
26.07.24
€102.80
Summary
This prediction is currently active. With a performance of -9.03%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 2.646% | 2.646% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€106.15
10.04.24
10.04.24
€167.24
10.04.25
10.04.25
-3.16%
26.07.24
26.07.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.90
29.02.24
29.02.24
€166.54
28.02.25
28.02.25
-6.46%
26.07.24
26.07.24